Ronald R. Blanck serves as Executive at OXYGEN BIOTHERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Ronald R. Blanck has executed 12 insider transactions totaling $44.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 18, 2020 involved purchasing 5,000 shares valued at $4.8K.
Ronald R. Blanck currently holds 6,062 shares of OXYGEN BIOTHERAPEUTICS, INC. (OXBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald R. Blanck has been a net buyer of OXBT stock. They have purchased $39.0K and sold $5.1K worth of shares.
Ronald R. Blanck's most recent insider trade was on May 18, 2020, when they purchased 5,000 shares at $0.95 per share.
Get notified when new Form 4 filings are submitted
| $0.45 |
| Discretionary |
| Dec 18, 2017 | TENX | $3.0K | Purchase | 6,475 | $0.46 | Discretionary |
| Nov 14, 2017 | TENX | $5.1K | Sale | 12,950 | $0.39 | Discretionary |
| May 23, 2016 | TENX | $9.2K | Disposition | 3,500 | $2.62 | Discretionary |
| Feb 2, 2016 | TENX | $4.8K | Disposition | 1,800 | $2.69 | Discretionary |
| Nov 19, 2015 | TENX | $15.3K | Purchase | 4,700 | $3.26 | Discretionary |
| Nov 19, 2015 | TENX | $6.1K | Purchase | 1,900 | $3.20 | Discretionary |
| Jan 20, 2015 | TENX | $7.0K | Purchase | 2,000 | $3.49 | Discretionary |
| May 1, 2012 | OXBT | $33.8K | Award | 18,961 | $1.78 | Discretionary |
| Nov 1, 2011 | OXBT | $20.1K | Award | 9,538 | $2.11 | Discretionary |
| Jun 24, 2011 | OXBT | $18.9K | Award | 7,490 | $2.52 | Discretionary |